WETS
INMB icon

Wealth Enhancement Trust Services’s INmune Bio INMB Stock Holding History

Wealth Enhancement Trust Services’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68 Buy
+42
New +$58 ﹤0.01% 1439

Other funds holding INMB

CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
AHL
Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Wealth Enhancement Trust Services's INMB Position: Q2 2026 in Review

Wealth Enhancement Trust Services opened a new position in INmune Bio (INMB) in Q2 2026: 42 shares worth $68. The stake represents ﹤0.01% of the portfolio and ranks #1439 among its holdings.

13 funds tracked by Wall St. Rank hold INMB as of Q2 2026.

  • Wealth Enhancement Trust Services held 42 shares of INmune Bio worth $68 as of Q2 2026.
  • INmune Bio was a new Wealth Enhancement Trust Services position in Q2 2026.
  • INmune Bio made up ﹤0.01% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #1439 holding.
  • 13 funds tracked by Wall St. Rank held INmune Bio as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.